Seminar 13 Immuno Prophylaxis

Embed Size (px)

Citation preview

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    1/26

    Immunoprophylaxis(prophylactic immunization)

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    2/26

    Immunoprophylaxis

    Types of immunization

    Immunoglobulins and vaccines

    Strategies in vaccine preparation

    Mechanisms of action of different types of vaccines

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    3/26

    NATURAL

    ARTIFICIAL

    (PROPHYLACTIC)

    ACTIVE

    PASSIV

    E

    IMMUNIZATION

    Immunity after infectionTransplacental transfer of IgG

    Immunoglobulines in milk

    (breast feeding)

    Immunoglobulins and

    antisera (antitoxins)

    Vaccination

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    4/26

    Pasive immunization(Administration of immunoglobulins/antisera)

    For prophylaxis or therapy

    Human immunoglobulins (from blood donors)

    Animal (horse) sera (antisera, antitoxins)

    e.g. for snake venoms, botulism, diphteria...

    immediate effect

    temporary immunity (weeks, months)

    Antibodies-Immunoglobulins (Ig)

    - human serum (gama)globulin (Ig of various specificity)

    - specific immune globulins (high-titre of specific Ig)

    serum disease!!!

    e.g. for hepatitis B, tetanus, rabies...

    e.g. for immunodeficiencies...

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    5/26

    Active immunization(Vaccination)

    Requires time (weeks) for induction of immune response

    Administration

    Long-lasting immunity

    - prior to exposure to pathogen (exception: rabies vaccine)

    - post-exposure (in combination with specific Ig)

    - multiple doses needed for most vaccines

    Herd immunity

    Primarily for prophylaxis

    Adjuvant

    - increases immunogenicity

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    6/26

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    7/26

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    8/26

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    9/26

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    10/26

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    11/26

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    12/26

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    13/26

    Vaccine types

    Live (attenuated) vaccines

    Inactivated (killed) vaccines

    - contain killed whole infectious agents

    Conjugate vaccines

    - contain structural parts/products of infectious agents

    New approches for vaccines

    obtained from pathogens by isolation and purification

    synthetic (genetic engineering)

    Subunit (antigenic) vaccines

    - contain live, attenuated (weakend) infectious agents

    Combined (polyvalent) vaccines

    - contain T-independent antigen bound to T-dependent antigen

    - contain several antigens of one or more different pathogens

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    14/26

    Live (attenuated) vaccines

    Examples

    Advantages

    Induction of both humoral (Abs) and cellular response (CTLs)

    Several viral vaccines (against polio (oral-Sabin), mumps, measles, rubella,

    varicella) and some bacterial (BCG for tuberculosis)...

    Long-lasting immunity (administered in one or two doses)

    Limitations

    Risk in immunocompromised persons

    Instability (termolabile)

    Principle

    Imunization with attenuated (weakened) pathogen

    BCG (limited efficacy)

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    15/26

    Inactivated (killed) vaccines

    Greater stability

    Vaccines against pertussis, typhoid, polio (Salk), influenza...

    Safety (no risk of infection)

    Shorter immunity (multiple, booster administration required)

    Low immunogenicity (only Ab induced, adjuvant required)

    Examples

    Advantages

    Limitations

    Principle

    Imunization with killed (inactivated) whole infective agents

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    16/26

    Subunit (antigenic) vaccines

    Vaccine against pertussis (acellular), tetanus and diphteria (toxoid),

    influenza (Hemagglutinin and Neuraminidase), hepatitis B (HBsAg) and

    human papilloma virus (L1 protein) so-called virus-like particles (VLP),

    pneumococcal and meningococcal polysaccharide vaccines...

    Same as for inactivated vaccines (lower immunogenecity)

    Examples

    Advantages

    Limitations

    Principle

    Same as for inactivated vaccines (greater safety)

    Immunization with structural antigens (protein or polysaccharide) of

    pathogens or their products (e.g. toxoid)

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    17/26

    Conjugate vaccinesPrinciple

    Immunization with capsular polysaccharide antigen of one pathogen(weak immunogen in children) conjugated to protein antigen of another

    pathogen (strong immunogen)

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    18/26

    Principle of immunization with conjugated vaccines

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    19/26

    Principle of immunization with conjugated vaccines

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    20/26

    Principle of immunization with conjugated vaccines

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    21/26

    Principle of immunization with conjugated vaccines

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    22/26

    Conjugate vaccines

    Good immune response to capsular antigens

    Vaccines against pneumococcus, menigococcus and H. influenzae type B(capsular polysaccharide bound to diptheria toxoid )

    Efficient in children in the first two years of life and asplenic persons

    Relatively high cost

    Same as for subunit vaccines

    Example

    Advantages

    Limitations

    Principle

    Immunization with capsular polysaccharide antigen of one pathogen(weak immunogen in children) conjugated to protein antigen of another

    pathogen (strong immunogen)

    Same as for subunit vaccines

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    23/26

    Combined (polyvalent) vaccines

    Practical (fewer administration, fewer visits of doctor...)

    Vaccines against tetanus, diphtera and pertussis (DTP), measles,

    mumps and rubella (MMR), polysaccharide or conjugate pneumococcal

    vaccines...

    Same as for single vaccines

    Examples

    Advantages

    Limitations

    Principle

    Simultaneous immunization with several serotypes of one pathogen

    (either attenuated strains or antigens) or several different pathogens

    The same as for appropriate single vaccinesGood immune response to every component in vaccine

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    24/26

    New approaches for vaccines(Hybride vaccines with live viral vectors)

    Immunization with live viral vectors (e.g. vaccinia virus) with

    introduced genes for immunodominant peptides of different pathogens

    Repeated administration not possible

    Ongoing clinical trials for several vaccines (e.g. against HIV)Examples

    Advantages

    Limitations

    Principle

    Induction of both humoral (Abs) and cellular immune response (CTLs)

    Possibility of polyvalent vaccine preparation

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    25/26

    Injection of bacterial plasmid with DNA containing genes for various

    microbial antigenes

    Mechanism of action and possible adverse effects not well understood

    Ongoing clinical trials for several pathogens

    Simple handling, possibility of polyvalent vaccines preparation

    Example

    Advantages

    Limitations

    Principle

    Induction of both humoral (Abs) and cellular immune response (CTLs)

    New approaches for vaccines(DNA vaccines)

  • 7/27/2019 Seminar 13 Immuno Prophylaxis

    26/26

    transplacental transfer of IgGj.Adjuvants increase10.

    immunogenicity of antigens in vaccinesi.Conjugate vaccines induce production of9.

    immunity after recovery from infectiousdisease

    h.Combined vaccines contain8.

    high-affinity antibodies to polysaccharidesg.Inactivated vaccines contain7.

    parts of infective agents or their productsf.

    Subunit vaccines contain6.

    induce production of mucosal IgAe.

    Live attenuated vaccine against polio5.

    whole killed microorganismsd.Example of natural passive

    immunization is

    4.

    immunity to tetanus after injection ofantitetanus immunoglobulins

    c.Example of natural active

    immunization is

    3.

    immunity to tetanus after injection of

    tetanus toxoid

    b.Example of artificial passive

    immunization is

    2.

    antigens from different infectious agentsa.Example of artificial active

    immunization is

    1.

    1. 2. 3. 4. 5. 6. 7. 8. 9. 10. b c h j e f d a g h